KeyMed Biosciences Inc
HKEX:2162
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
KeyMed Biosciences Inc
HKEX:2162
|
CN |
|
C
|
Chefs' Warehouse Inc
SWB:2CF
|
US |
|
Cadre Holdings Inc
NYSE:CDRE
|
US |
|
CME Group Inc
NASDAQ:CME
|
US |
|
Novartis AG
SIX:NOVN
|
CH |
|
Prosegur Compania de Seguridad SA
MAD:PSG
|
ES |
|
Nurix Therapeutics Inc
NASDAQ:NRIX
|
US |
|
TAL Education Group
NYSE:TAL
|
CN |
|
Y
|
Yamana Gold Inc
SIX:YRI
|
CA |
|
Blue Owl Capital Inc
NYSE:OWL
|
US |
|
Konami Holdings Corp
TSE:9766
|
JP |
|
Albemarle Corp
NYSE:ALB
|
US |
|
Hain Celestial Group Inc
NASDAQ:HAIN
|
US |
|
International Flavors & Fragrances Inc
NYSE:IFF
|
US |
|
Perimeter Solutions SA
NYSE:PRM
|
LU |
Shareholder Yield
Current shareholder yield for KeyMed Biosciences Inc is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
KeyMed Biosciences Inc
| Average Annual Return | -8.88% |
| Standard Deviation of Annual Returns | 52.12% |
| Max Drawdown | -75% |
| Market Capitalization | 17.3B HKD |
| Shares Outstanding | 298 740 000 |
| Percentage of Shares Shorted |
N/A
|
